This HTML5 document contains 127 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n12http://dx.doi.org/10.1371/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n9http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q57040963
rdf:type
wikibase:Item
schema:description
scientific article published in PLoS ONE наукова стаття, опублікована у 2018 wetenschappelijk artikel artículu científicu im Januar 2018 veröffentlichter wissenschaftlicher Artikel article publié dans la revue scientifique PLoS ONE
p:P577
wds:Q57040963-D63498CB-1900-45F8-BB52-76C481E8A267
wdt:P577
2018-10-03T00:00:00Z
p:P407
wds:Q57040963-B1F52635-D410-4058-971A-1DA531C334E6
wdt:P407
wd:Q1860
p:P2860
wds:Q57040963-750E39FD-DA94-4FF0-8AB2-F31B41599A94 wds:Q57040963-1E6F80C3-03C6-4768-A5D0-EDF4E359E731 wds:Q57040963-20E89FCD-E831-4308-B9FA-BC595A1D0861 wds:Q57040963-01EB2229-7BA8-4500-8CC0-19D577853493 wds:Q57040963-13CD265E-C2B4-4D59-AB68-D826E2861C11 wds:Q57040963-11BA2CA9-1D25-47EA-9730-F88E9A8C44B3 wds:Q57040963-3B454B40-784F-44B6-9717-AAE177CB22A0 wds:Q57040963-2BFA50BC-44BC-4928-9A35-7D2665579F02 wds:Q57040963-47137C5F-76DA-467D-AE26-5C3842A757FC wds:Q57040963-264F9928-01A7-4154-AC11-E738BB2BD0CB wds:Q57040963-241998C8-356D-4287-A47E-F16145FC46F8 wds:Q57040963-29223964-E5EF-4E91-9C12-D078A6DE1DD0 wds:Q57040963-F94E8A5B-CE97-48B2-8F54-936C7755C85D wds:Q57040963-F7DA8A80-5B7B-4B7C-93ED-8CFB4D68EB4B wds:Q57040963-FA97AE38-8F80-427C-AF0C-3AEC4A7F44B7 wds:Q57040963-DDEB66A3-9149-4EA8-9135-E26C1FD370AD wds:Q57040963-D9C8D32E-6342-414F-837B-CC2A17DF3450 wds:Q57040963-9C4F1788-32E0-4C44-A1A2-BF3DCB9CADD6 wds:Q57040963-AAA17724-B89B-4C1E-A380-881D36C37784 wds:Q57040963-A2D63A48-03AE-48FB-95A5-F01BD17E70B1 wds:Q57040963-88ADB45D-ADF7-4128-8261-891D9AFE4868 wds:Q57040963-86B5BDDF-FFD4-46E4-B883-643DBE2BB0E6 wds:Q57040963-9A18B408-0F0C-4419-8CB3-23492D689CD5 wds:Q57040963-C8C50C78-C807-4375-BB3D-D21DDAA1A5D4 wds:Q57040963-C6F479B7-F805-4BAC-9953-D1D19451022F wds:Q57040963-BAC34A14-4953-4DF7-9CB1-9DBB7CDA13E8 wds:Q57040963-6077186E-FB8A-46B7-ADC5-7BF9C6C5EC0B wds:Q57040963-50B7F59C-0B0D-4A66-A626-318E41A945B5 wds:Q57040963-5AE9A8DD-3EF1-4D24-A345-EB0650E99A17 wds:Q57040963-58E55CB4-4DA2-4E88-898B-0C65B9736621 wds:Q57040963-82ED2FE9-B766-47BF-BADA-4A4DF5A77106 wds:Q57040963-773B9947-BAF7-42C1-A6C5-2D42E6936CC4 wds:Q57040963-862B0D3B-62BA-43BD-9E97-9427E8084D02 wds:Q57040963-84FE0584-4C2E-45CC-94D4-8EAE5C4BB0F9
wdt:P2860
wd:Q42197246 wd:Q39359613 wd:Q40049823 wd:Q42699381 wd:Q35864200 wd:Q24629455 wd:Q33650138 wd:Q35841089 wd:Q33711886 wd:Q33488345 wd:Q42345066 wd:Q39768496 wd:Q36343824 wd:Q38692113 wd:Q45733180 wd:Q40278327 wd:Q42633467 wd:Q42699385 wd:Q64132028 wd:Q36347429 wd:Q38984449 wd:Q41078074 wd:Q40476713 wd:Q24630669 wd:Q37479877 wd:Q34645642 wd:Q52280951 wd:Q30957144 wd:Q39788156 wd:Q35860136 wd:Q33687240 wd:Q34691743 wd:Q39734480 wd:Q38123945
p:P2093
wds:Q57040963-6EC2B36C-70C9-4BF1-9864-1BA774695122 wds:Q57040963-72BE4B37-AB6C-4427-A843-A7B68C0B8305 wds:Q57040963-A2B6E599-6444-4C81-9E06-5281F6EE1CFB wds:Q57040963-BEF6F8B5-85FD-42BE-B708-15B75DC217AD wds:Q57040963-CC06AC42-0A76-44B6-9DBD-9FBBEB7C966D wds:Q57040963-F67DA6E4-474E-4873-8079-20F3B1E07B5A
wdt:P2093
Jorge Gutiérrez Santiago Moreno Jesús Troya Alejandro Alvaro-Meca Pablo Ryan Guillermo Cuevas
rdfs:label
HCV seroconversion in a cohort of people who use drugs followed in a mobile harm reduction unit in Madrid: Breaking barriers for HCV elimination HCV seroconversion in a cohort of people who use drugs followed in a mobile harm reduction unit in Madrid: Breaking barriers for HCV elimination
skos:prefLabel
HCV seroconversion in a cohort of people who use drugs followed in a mobile harm reduction unit in Madrid: Breaking barriers for HCV elimination HCV seroconversion in a cohort of people who use drugs followed in a mobile harm reduction unit in Madrid: Breaking barriers for HCV elimination
schema:name
HCV seroconversion in a cohort of people who use drugs followed in a mobile harm reduction unit in Madrid: Breaking barriers for HCV elimination HCV seroconversion in a cohort of people who use drugs followed in a mobile harm reduction unit in Madrid: Breaking barriers for HCV elimination
p:P50
wds:Q57040963-1828E5F1-7B66-4546-AA3C-56AB68A6B124
wdt:P50
wd:Q90743380
p:P1476
wds:Q57040963-7224FF10-45CE-4A5E-B288-3D1DEE994328
wdt:P1476
HCV seroconversion in a cohort of people who use drugs followed in a mobile harm reduction unit in Madrid: Breaking barriers for HCV elimination
p:P304
wds:Q57040963-3B945279-C0FD-4902-AC88-4FC0A00E5649
wdt:P304
e0204795
p:P31
wds:Q57040963-47B8F975-66A6-4939-A7E1-DCDA8890A013
wdt:P31
wd:Q13442814
p:P921
wds:Q57040963-1E730FDA-0FCE-4159-B6BF-31ACDBAA7BC4 wds:Q57040963-EC618423-52B7-4C22-B351-643B3CDA8590
wdt:P921
wd:Q2141450 wd:Q1458711
p:P698
wds:Q57040963-72D6DA22-FCA5-49CA-8655-314B0CFA6EEE
wdtn:P698
n9:30281616
wdt:P698
30281616
p:P1433
wds:Q57040963-5EFDDE1C-7D19-4D66-914E-EA82509F32F7
wdt:P1433
wd:Q564954
p:P433
wds:Q57040963-65F660A2-EB67-4C91-92C8-D0F67978B716
p:P478
wds:Q57040963-26CE591B-5ABB-4547-9AD3-D75D10EFB154
wdt:P433
10
wdt:P478
13
p:P356
wds:Q57040963-B232B6EA-2077-4CB9-BF8A-9114EA2FF76F
wdtn:P356
n12:JOURNAL.PONE.0204795
wdt:P356
10.1371/JOURNAL.PONE.0204795
p:P275
wds:Q57040963-a11f7ec1-adb6-4cc8-ba90-4023192a49c3
p:P6216
wds:Q57040963-e0e150eb-0eec-4f87-8c90-15c02380ffd2
wdt:P275
wd:Q20007257
wdt:P6216
wd:Q50423863
p:P932
wds:Q57040963-8AA4644B-CFAF-42A5-B05A-4860CF55F488
wdt:P932
6169909